- Authors: Darade AR. et al.
- Year: 2022
- Journal: Pharmaceutics 14 151
- Applications: in vitro / mRNA / in vivo-jetPEI, jetMESSENGER
- Cell type: ex vivo porcine skin model
Before administration, mRNAs were mixed with transfection agents. Two different transfection agents were studied; a polymer-based transfection agent (in vivo jet-PEI®; Polyplus transfection, Illkirch, France) and a liposomal system (jetMESSENGER™; Polyplus transfection, Illkirch, France).
In vitro transcribed messenger ribonucleic acid (mRNA) constitutes an emerging therapeutic class with several clinical applications. This study presents a systematic comparison of different technologies-intradermal injection, microneedle injection, jet injection, and fractional laser ablation-for the topical cutaneous delivery of mRNA. Delivery of Cy5 labeled mRNA and non-labeled enhanced green fluorescent protein (eGFP) expressing mRNA was investigated in a viable ex vivo porcine skin model and monitored for 48 h. Forty 10 µm-thick horizontal sections were prepared from each skin sample and Cy5 labeled mRNA or eGFP expression visualized as a function of depth by confocal laser scanning microscopy and immunohistochemistry. A pixel-based method was used to create a semi-quantitative biodistribution profile. Different spatial distributions of Cy5 labeled mRNA and eGFP expression were observed, depending on the delivery modality; localization of eGFP expression pointed to the cells responsible. Delivery efficiencies and knowledge of delivery sites can facilitate development of efficient, targeted mRNA-based therapeutics.